|
TMEM135 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71185288166953E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05859765398009E-11 |
| Normal-vs-Stage2 |
6.754800E-04 |
| Normal-vs-Stage3 |
8.58202398035246E-14 |
| Normal-vs-Stage4 |
1.62492241884138E-12 |
| Stage1-vs-Stage2 |
3.767900E-02 |
| Stage1-vs-Stage3 |
3.939900E-02 |
| Stage1-vs-Stage4 |
1.027260E-04 |
| Stage2-vs-Stage3 |
1.279620E-03 |
| Stage2-vs-Stage4 |
4.01490000000448E-05 |
| Stage3-vs-Stage4 |
8.982100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.27435864480685E-14 |
| Normal-vs-AfricanAmerican |
3.282300E-03 |
| Normal-vs-Asian |
1.67899028014062E-12 |
| Caucasian-vs-AfricanAmerican |
2.487200E-01 |
| Caucasian-vs-Asian |
2.677800E-02 |
| AfricanAmerican-vs-Asian |
7.077900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.92734758445113E-12 |
| Normal-vs-Female |
2.38509212380222E-12 |
| Male-vs-Female |
2.712400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.82309764243882E-11 |
| Normal-vs-Age(41-60Yrs) |
3.51241258300661E-12 |
| Normal-vs-Age(61-80Yrs) |
1.56470003620512E-09 |
| Normal-vs-Age(81-100Yrs) |
2.381600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.120600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.541000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.651000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.242000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.520800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.923400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.09690001526275E-09 |
| Classical-VS-Follicular |
2.01429999999725E-05 |
| Classical-VS-Other |
9.671400E-01 |
| Classical-VS-Normal |
1.62903024403249E-12 |
| Tall-VS-Follicular |
1.6530110613644E-12 |
| Tall-VS-Other |
1.987990E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.844640E-01 |
| Follicular-VS-Normal |
3.277000E-03 |
| Other-VS-Normal |
3.624700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89729998378851E-09 |
| Normal-vs-N1 |
2.77555756156289E-15 |
| N0-vs-N1 |
1.958340E-04 |
|
|
